These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
465 related articles for article (PubMed ID: 32387442)
1. Metabolic alterations in the tumor microenvironment and their role in oncogenesis. Eisenberg L; Eisenberg-Bord M; Eisenberg-Lerner A; Sagi-Eisenberg R Cancer Lett; 2020 Aug; 484():65-71. PubMed ID: 32387442 [TBL] [Abstract][Full Text] [Related]
2. Metabolic reprogramming and crosstalk of cancer-related fibroblasts and immune cells in the tumor microenvironment. Zhu Y; Li X; Wang L; Hong X; Yang J Front Endocrinol (Lausanne); 2022; 13():988295. PubMed ID: 36046791 [TBL] [Abstract][Full Text] [Related]
3. Metabolic reprogramming of cancer-associated fibroblasts and its effect on cancer cell reprogramming. Li Z; Sun C; Qin Z Theranostics; 2021; 11(17):8322-8336. PubMed ID: 34373744 [TBL] [Abstract][Full Text] [Related]
4. Ovarian cancer cell-derived lysophosphatidic acid induces glycolytic shift and cancer-associated fibroblast-phenotype in normal and peritumoral fibroblasts. Radhakrishnan R; Ha JH; Jayaraman M; Liu J; Moxley KM; Isidoro C; Sood AK; Song YS; Dhanasekaran DN Cancer Lett; 2019 Feb; 442():464-474. PubMed ID: 30503552 [TBL] [Abstract][Full Text] [Related]
5. Metabolic Relationship between Cancer-Associated Fibroblasts and Cancer Cells. Sazeides C; Le A Adv Exp Med Biol; 2018; 1063():149-165. PubMed ID: 29946782 [TBL] [Abstract][Full Text] [Related]
6. The promising therapeutic effects of metformin on metabolic reprogramming of cancer-associated fibroblasts in solid tumors. Mostafavi S; Zalpoor H; Hassan ZM Cell Mol Biol Lett; 2022 Jul; 27(1):58. PubMed ID: 35869449 [TBL] [Abstract][Full Text] [Related]
7. Targeting Metabolic Cross Talk between Cancer Cells and Cancer-Associated Fibroblasts. Jung JG; Le A Adv Exp Med Biol; 2018; 1063():167-178. PubMed ID: 29946783 [TBL] [Abstract][Full Text] [Related]
8. The Engaged Role of Tumor Microenvironment in Cancer Metabolism: Focusing on Cancer-Associated Fibroblast and Exosome Mediators. Ilkhani K; Bastami M; Delgir S; Safi A; Talebian S; Alivand MR Anticancer Agents Med Chem; 2021; 21(2):254-266. PubMed ID: 32914721 [TBL] [Abstract][Full Text] [Related]
9. Role of miRNAs in cell signaling of cancer associated fibroblasts. Eichelmann AK; Matuszcak C; Hummel R; Haier J Int J Biochem Cell Biol; 2018 Aug; 101():94-102. PubMed ID: 29807095 [TBL] [Abstract][Full Text] [Related]
10. Cancer associated fibroblasts and metabolic reprogramming: unraveling the intricate crosstalk in tumor evolution. Zhang F; Ma Y; Li D; Wei J; Chen K; Zhang E; Liu G; Chu X; Liu X; Liu W; Tian X; Yang Y J Hematol Oncol; 2024 Sep; 17(1):80. PubMed ID: 39223656 [TBL] [Abstract][Full Text] [Related]
11. 'Reverse Warburg effect' of cancer‑associated fibroblasts (Review). Liang L; Li W; Li X; Jin X; Liao Q; Li Y; Zhou Y Int J Oncol; 2022 Jun; 60(6):. PubMed ID: 35425996 [TBL] [Abstract][Full Text] [Related]
12. Metabolic cooperation between cancer and non-cancerous stromal cells is pivotal in cancer progression. Lopes-Coelho F; Gouveia-Fernandes S; Serpa J Tumour Biol; 2018 Feb; 40(2):1010428318756203. PubMed ID: 29421992 [TBL] [Abstract][Full Text] [Related]
13. Metabolic Reprogramming of Cancer Associated Fibroblasts: The Slavery of Stromal Fibroblasts. Avagliano A; Granato G; Ruocco MR; Romano V; Belviso I; Carfora A; Montagnani S; Arcucci A Biomed Res Int; 2018; 2018():6075403. PubMed ID: 29967776 [TBL] [Abstract][Full Text] [Related]
14. Stromal reprogramming: A target for tumor therapy. Najafi M; Mortezaee K; Majidpoor J Life Sci; 2019 Dec; 239():117049. PubMed ID: 31730862 [TBL] [Abstract][Full Text] [Related]
15. Carcinoma-Associated Mesenchymal Stem/Stromal Cells: Architects of the Pro-tumorigenic Tumor Microenvironment. Frisbie L; Buckanovich RJ; Coffman L Stem Cells; 2022 Aug; 40(8):705-715. PubMed ID: 35583414 [TBL] [Abstract][Full Text] [Related]
16. Cancer-associated fibroblasts: Mediators of head and neck tumor microenvironment remodeling. Raudenska M; Balvan J; Hanelova K; Bugajova M; Masarik M Biochim Biophys Acta Rev Cancer; 2023 Sep; 1878(5):188940. PubMed ID: 37331641 [TBL] [Abstract][Full Text] [Related]
17. Regulation of Tumor Immune Microenvironment by Sphingolipids and Lysophosphatidic Acid. Vishwakarma S; Arya N; Kumar A Curr Drug Targets; 2022; 23(6):559-573. PubMed ID: 34879798 [TBL] [Abstract][Full Text] [Related]
18. Metabolic crosstalk in the breast cancer microenvironment. Dias AS; Almeida CR; Helguero LA; Duarte IF Eur J Cancer; 2019 Nov; 121():154-171. PubMed ID: 31581056 [TBL] [Abstract][Full Text] [Related]
19. Unlocking the potential: Targeting metabolic pathways in the tumor microenvironment for Cancer therapy. Jia S; Bode AM; Chen X; Luo X Biochim Biophys Acta Rev Cancer; 2024 Sep; 1879(5):189166. PubMed ID: 39111710 [TBL] [Abstract][Full Text] [Related]
20. Multi‑faceted role of cancer‑associated adipocytes in the tumor microenvironment (Review). Yao H; He S Mol Med Rep; 2021 Dec; 24(6):. PubMed ID: 34676881 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]